Skip to main content

$0.265 0.005 (1.92%)

High

$0.27

Low

$0.26

Trades

10

Turnover

$30,696

Volume

117,402
30 June 2023 at 3:52pm
Register to track EYE and receive email alerts.

Clinical trial to Assess Efficacy and Safety of i Track

StockBot

416,823 posts

EYE released this announcement to the ASX on 2 March 2021, 8:40. The announcement is marked as price sensitive, and is 4 page(s) in length and 299.36kb in size.

You can view all announcements from EYE and see how they appear on a price chart on the announcements page.

At the date of this announcement, EYE was 0.012% short sold according to ASIC data. It was ranked the 530th most shorted stock on the ASX. It remains ranked 571st as of the latest reported data (10 April 2025).

Other Recent Announcements from EYE
Investment Presentation 19 May 2023, 12:28
Change of Director's Interest Notice 10 May 2023, 15:56
Change of Director's Interest Notice 10 May 2023, 15:55
Clinical trial to Assess Efficacy and Safety of i Track 2 March 2021, 8:40
Investor presentation Half year Results 31 December 2020 25 February 2021, 8:29
Half Year Results Discussion 25 February 2021, 8:28
Half Year Accounts 25 February 2021, 8:24
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track EYE and receive email alerts.